These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37926530)

  • 21. Inhibition of Urease Enzyme Production and some Other Virulence Factors Expression in Proteus mirabilis by N-Acetyl Cysteine and Dipropyl Disulphide.
    Abdel-Baky RM; Ali MA; Abuo-Rahma GEAA; AbdelAziz N
    Adv Exp Med Biol; 2017; 973():99-113. PubMed ID: 28190143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Pathogenic Potential of Proteus mirabilis Is Enhanced by Other Uropathogens during Polymicrobial Urinary Tract Infection.
    Armbruster CE; Smith SN; Johnson AO; DeOrnellas V; Eaton KA; Yep A; Mody L; Wu W; Mobley HLT
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reduced consciousness levels caused by hyperammonaemia].
    Driessen LM; du Pré BC; Schuit SCE; Langendonk JG; Zandbergen AAM; Wagenmakers MAEM
    Ned Tijdschr Geneeskd; 2019 Oct; 163():. PubMed ID: 31609561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic resistance pattern among biofilm producing and non producing Proteus strains isolated from hospitalized patients; matter of hospital hygiene and antimicrobial stewardship.
    Shikh-Bardsiri H; Shakibaie MR
    Pak J Biol Sci; 2013 Nov; 16(22):1496-502. PubMed ID: 24511691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections.
    Dattelbaum JD; Lockatell CV; Johnson DE; Mobley HL
    Infect Immun; 2003 Feb; 71(2):1026-30. PubMed ID: 12540589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Septic discitis and septic pulmonary emboli: rare complications of
    Ahmad S; Cutrone M; Ikram S; Yousaf A
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34426427
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperammonemia in a boy with obstructive ureterocele and proteus infection.
    Sinha B; Gonzalez R
    J Urol; 1984 Feb; 131(2):330-1. PubMed ID: 6699967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Rare Opportunist,
    Learman BS; Brauer AL; Eaton KA; Armbruster CE
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31611275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystallization of urine mineral components may depend on the chemical nature of Proteus endotoxin polysaccharides.
    Torzewska A; Stączek P; Róźalski A
    J Med Microbiol; 2003 Jun; 52(Pt 6):471-477. PubMed ID: 12748265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Urease activity of bacteria in urine].
    Arai Y; Takeuchi H; Tomoyoshi T; Tatewaki K
    Hinyokika Kiyo; 1989 Feb; 35(2):277-81. PubMed ID: 2500012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteus mirabilis Overview.
    Mobley HLT
    Methods Mol Biol; 2019; 2021():1-4. PubMed ID: 31309490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitors of bacterial urease: microbiological considerations on hydroxyurea influenza virus.
    Perrone G; Ferrari C; Arghittu M
    Boll Ist Sieroter Milan; 1982; 61(6):513-5. PubMed ID: 6765400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections.
    Hola V; Peroutkova T; Ruzicka F
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):343-9. PubMed ID: 22533980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Case of Infectious Enterocolitis with Hyperammonemia.
    Otsuji K; Simizu S; Endo T; Kanazawa A; Arai H; Nagata K; Harayama N; Nihei S; Aibara K; Saito M; Kamochi M
    J UOEH; 2017; 39(4):271-276. PubMed ID: 29249740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression.
    Pearson MM; Yep A; Smith SN; Mobley HL
    Infect Immun; 2011 Jul; 79(7):2619-31. PubMed ID: 21505083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of infected urinary stones in rats by urease inhibitor: a new hydroxamic acid derivative.
    Takeuchi H; Kobashi K; Yoshida O
    Invest Urol; 1980 Sep; 18(2):102-5. PubMed ID: 6997228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascending urinary tract infections in rats induced by Staphylococcus saprophyticus and Proteus mirabilis.
    Hjelm E; Lundell-Etherden I; Mårdh PA
    Acta Pathol Microbiol Immunol Scand B; 1987 Dec; 95(6):347-50. PubMed ID: 3326399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis of Proteus mirabilis urinary tract infection.
    Coker C; Poore CA; Li X; Mobley HL
    Microbes Infect; 2000 Oct; 2(12):1497-505. PubMed ID: 11099936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A small-molecular inhibitor against Proteus mirabilis urease to treat catheter-associated urinary tract infections.
    Milo S; Heylen RA; Glancy J; Williams GT; Patenall BL; Hathaway HJ; Thet NT; Allinson SL; Laabei M; Jenkins ATA
    Sci Rep; 2021 Feb; 11(1):3726. PubMed ID: 33580163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of urease in pyelonephritis resulting from urinary tract infection with Proteus.
    Musher DM; Griffith DP; Yawn D; Rossen RD
    J Infect Dis; 1975 Feb; 131(2):177-81. PubMed ID: 234993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.